Aspergilli Response to Benzalkonium Chloride and Novel-Synthesized Fullerenol/Benzalkonium Chloride Nanocomposite

Figure 4

Mycelial growth inhibition in 21-day-old Aspergillus spp. cultures treated with benzalkonium chloride concentrations of 0.03 μg mL⁻¹, 0.15 μg mL⁻¹, and 0.6 μg mL⁻¹ (a) and fullerenol/benzalkonium chloride concentrations of 0.05/0.03 μg mL⁻¹, 0.26/0.15 μg mL⁻¹, and 1.04/0.6 μg mL⁻¹ (b). Results are expressed as means ± standard error of values obtained from triplicate experiments ().

(a)

(b)